Incidence rates of acute promyelocytic leukemia among Hispanics, blacks, Asians, and non-Hispanic whites in the United States

European Journal of Cancer Prevention

Volumn 15, Issue 4, 2006, Pages 367-370

  Matasar, Matthew J ^a,b   Ritchie, Ellen K ^b   Consedine, Nathan ^c   Magai, Carol ^c   Neugut, Alfred I ^a,b  

^a Mailman School of Public Health ^*  (United States)

^b Columbia University ^*  (United States)

^c LONG ISLAND UNIVERSITY   (United States)

Author keywords

Acute; And End Results program; Epidemiology; Ethnic groups; Leukemia; Promyelocytic; Surveillance

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CANCER CENTER; CANCER INCIDENCE; CHILD; COHORT ANALYSIS; DATA ANALYSIS; ETHNOLOGY; FEMALE; HEALTH PROGRAM; HISPANIC; HUMAN; INFANT; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RACE; RETROSPECTIVE STUDY; SEX; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LEUKEMIA, PROMYELOCYTIC, ACUTE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 33745940577     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200608000-00011     Document Type: Article

References (22)

1. Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L, et al. (2003). Therapy-related acute promyelocytic leukemia. J Clin Oncol 21:2123-2137.
2. Boza WB, Cruz GJ, Saenz MP, Umana CM (2004). High incidence of acute promyelocytic leukemia in the Caucasian population: the Costa Rica experience. Am J Hematol 76:96-97.
3. Douer D (2003). The epidemiology of acute promyelocytic leukaemia. Bailliere's Best Pract Clin Haematol 16:357-367.
4. Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, Levine AM (1996). High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 87:308-313 [see comment].
5. Douer D, Santillana S, Ramezani L, Samanez C, Slovak ML, Lee MS, et al. (2003). Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARalpha fusion gene. Br J Haematol 122:563-570.
6. Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M (1997). Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia 11:1661-1664 [see comment].
7. Fang J, Chen SJ, Tong JH, Wang ZG, Chen GQ, Chen Z (2002). Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy. Cancer Biol Ther 1:614-620.
8. Grimwade D, Enver T (2004). Acute promyelocytic leukemia: where does it stem from? Leukemia 18:375-384.
9. Hernandez P, Milanes MT, Svarch E, Martinez G, Ballester JM (2000). High relative proportion of acute promyelocytic leukemia in children: experience of a multicenter study in Cuba. Leuk Res 24:739-740.
10. Keung YK, Chen SC, Groshen S, Douer D, Levine AM (1994). Acute myeloid leukemia subtypes and response to treatment among ethnic minorities in a large US urban hospital. Acta Haematol 92:18-22.
11. Malta Corea A, Pacheco Espinoza C, Cantu Rajnolid A, Conter V, Lietti G, Masera G, et al. (1993). Childhood acute promyelocytic leukemia in Nicaragua. Ann Oncol 4:892-894.
12. Otero JC, Santillana S, Fereyos G (1996). High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood 88:377 [comment].
13. Paltiel O, Harlap S, Deutsch L, Knaanie A, Massalha S, Tiram E, et al. (2004). Birth weight and other risk factors for acute leukemia in the Jerusalem Perinatal Study cohort. Cancer Epidemiol Biomarkers Prevent 13: 1057-1064.
14. Pulsoni A, Pagano L, Lo Coco F, Avvisati G, Mele L, Di Bona E, et al. (2002). Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Blood 100:1972-1976.
15. Ruiz-Arguelles GJ (1997). Promyelocytic leukemia in Mexican estizos. Blood 89:348-349 [comment].
16. Ruiz-Arguelles GJ, Garces-Eisele J, Reyes-Nunez V, Gomez-Rangel JD, Ruiz-Delgado GJ (2004). More on geographic hematology: the breakpoint cluster regions of the PML/RARalpha fusion gene in Mexican Mestizo patients with promyelocytic leukemia are different from those in Caucasians. Leuk Lymph 45:1365-1368.
17. Shen ZX, Shi ZZ, Fang J, Gu BW, Li JM, Zhu YM, et al. (2004). All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A 101:5328-5335.
18. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. (1998). Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341-1348 [see comment].
19. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, et al. (1997). All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1021-1028 [see comment] [erratum appears in N Engl J Med 1997; 337:1639].
20. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, et al. (2002). All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 100:4298-4302.
21. Tomas JF, Fernandez-Ranada JM (1996). About the increased frequency of acute promyelocytic leukemia among Latinos: the experience from a center in Spain. Blood 88:2357-2358 [comment].
22. Xue Y, Lu D, Guo Y, Lin B (1992). Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis. Leuk Res 16:1113-1123.